Specification
Description
Prurisol, also known as abacavir hydroxyacetate and KM-133, is potentially for the treatment of plaque psoriasis
Synonyms
KM-133; KM133; KM 133; Prurisol; Abacavir acetate; Abacavir hydroxyacetate
IUPAC Name
((1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methyl 2-hydroxyacetate
Canonical SMILES
O=C(OC[C@@H]1C=C[C@H](N2C=NC3=C(NC4CC4)N=C(N)N=C23)C1)CO
InChI
InChI=1S/C16H20N6O3/c17-16-20-14(19-10-2-3-10)13-15(21-16)22(8-18-13)11-4-1-9(5-11)7-25-12(24)6-23/h1,4,8-11,23H,2-3,5-7H2,(H3,17,19,20,21)/t9-,11+/m1/s1
InChI Key
ZBBZROWQLKCFQK-KOLCDFICSA-N
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Storage
Dry, dark and at 0-4 °C for short term (days to weeks) or -20 °C for long term (months to years).
Alternative CAS
136470-78-5 (free base); 136777-48-5 (HCl); 168146-84-7 (succinate); 188062-50-2 (sulfate); 1446418-48-9 (hydroxyacetate) 384380-52-3 (caeboxylate)
Biological Target
KM-133 is potential treatment for plaque psoriasis.
Drug Formulation
This drug may be formulated in DMSO
Elemental Analysis
C, 55.80; H, 5.85; N, 24.40; O, 13.94
HS Tariff Code
2934.99.9001
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Stock Solution Storage
0-4 °C for short term (days to weeks), or -20 °C for long term (months).